Observation of therapeutic effect of diarrhea predominant irritable bowel syndrome treated by combination of Birid Triple Viable,Otilonium Bromide tablets,Compound Glutamin Entresoluble capsules and Flupentixol Melitracen tablets
Objective To observe the therapeutic effect of diarrhea predominant irritable bowel syndrome treated by combination of Birid Triple Viable,Otilonium Bromide tablets,Compound Glutamin Entresoluble capsules and Flupentixol Melitracen tablets. Methods 120 patients with diarrhea predominant irritable bowel syndrome were randomly divided into three groups, they were A group,B group,C group. 40 cases in control group were treated by Birid Triple Viable, Otilonium Bromide tablets, Compound Glutamin Entresoluble capsules. 40 patients in control group were treated by Birid Triple Viable, Otilonium Bromide tablets .Compound Glutamin Entresoluble capsules and Oryzanol. 40 cases in treatment group were treated by Birid Triple Viable, Otilonium Bromide tablets. Compound Glutamin Entresoluble capsules and Flupentixol Melitracen tablets. The effect and side effect were observed after a course(4 weeks). Results A group,B group and C group were statistically significant difference in efficiency(P< 0. 05). By each group pairwise comparisons between treatments, A group,B group and C group had significant differences'. P<0. 05). The total effective rate in treatment group)95.0%) was higher than that in control group)82. 5%, 62. 5% ,P<0. 05). The tolerance and safety of medicine in three groups was good. There was no obvious side effect. Conclusion The effect of combination of Birid Triple Viable, Otilonium Bromide tablets,Compound Glutamin Entresoluble capsules and Flupentixol Melitracen tablets is definite on diarrhea predominant irritable bowel syndrome.
Irritable Bowel Syndromedrug therapyProbioticstherapeutic useQuaternary Ammonium Compoundstherapeutic useGlutaminerherapeutic useFlupenthixoltherapeutic use
NETL
NSTL
万方数据
维普
